Publications by authors named "K V Bulygin"
Recent developments in Achilles tendon risk-analyzing rupture factors for enhanced injury prevention and clinical guidance: Current implications of regenerative medicine.
J Orthop Translat
November 2024
Article Synopsis
- Many countries have increased focus on physical education and sports, yet there's been a notable rise in injuries, particularly Achilles tendon ruptures, which make up 47% of such cases.
- The review aims to identify risk factors for Achilles tendon ruptures and propose personalized prevention strategies based on extensive database research.
- It highlights non-modifiable factors like genetics and age as well as modifiable factors such as nutrition and exercise habits, emphasizing the importance of early treatment and the latest advancements in injury management.
Context: The problem of correcting immune system function and compensating for co-morbidities becomes particularly clinically significant in the post-COVID period. There is evidence that certain trace elements in the human body, particularly zinc ions, play a critical role in restoring the function of the immune system and internal organs.
Objective: To analyze the mechanisms of zinc action maintaining the body homeostasis in order to justify pathogenetically the inclusion of zinc drugs in the therapy of patients in the post-COVID period.
Background: Tracheal, Bronchus, and Lung (TBL) cancer continues to represent the majority of cancer-related incidence and mortality in United States (U.S.).
View Article and Find Full Text PDFArticle Synopsis
- This study explored the potential link between radiotherapy (RT) given for esophageal cancer (EC) and the risk of developing secondary head and neck cancer (SHNC).
- Using data from the SEER database, researchers found that EC patients who received RT had a higher incidence of SHNC compared to those who did not receive radiation, with significantly lower overall survival rates for RT patients who developed SHNC.
- The findings suggest that radiation oncologists should consider strategies to reduce the long-term risk of SHNC in EC patients treated with RT.
Previous studies described that asthma patients who received corticosteroid therapy have been constrained by the corticosteroid resistance subsequently fostered to severe refractory asthma. In this review, we discussed the implications of TSLP, RXR, the role of STAT5-activating cytokines, and IL-33/NH-cell signaling pathways, and recent clinical evidence on TSLP blockers in steroid-resistant asthma. We have searched several public databases such as Pubmed, Scopus, and Relemed and obtained information pertinent to the TSLP, RXR, TSLP blockers, the STAT5-activating cytokines, and IL-33.
View Article and Find Full Text PDF